Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DCL84J
|
|||
| Drug Name |
VLA1601
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Zika virus infection [ICD-11: 1D48] | Phase 1 | [1] | |
| Company |
Valneva
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03425149) Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.